X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (303) 303
male (198) 198
female (159) 159
index medicus (139) 139
adult (134) 134
middle aged (99) 99
psychiatry (79) 79
neurocognitive disorders - chemically induced (71) 71
cognition disorders - chemically induced (70) 70
animals (68) 68
neurosciences (58) 58
aged (57) 57
neurocognitive disorders - drug therapy (54) 54
neuropsychological tests (52) 52
adolescent (43) 43
cognition (38) 38
child (37) 37
neurocognitive disorders - diagnosis (37) 37
pharmacology & pharmacy (37) 37
clinical neurology (36) 36
schizophrenia (35) 35
article (33) 33
neurocognitive disorders (33) 33
analysis (32) 32
memory (32) 32
neurocognitive disorders - etiology (32) 32
brain (30) 30
schizophrenia - drug therapy (30) 30
neurocognitive deficits (28) 28
neurocognitive disorders - psychology (28) 28
brain - drug effects (26) 26
disease models, animal (26) 26
rats (26) 26
dose-response relationship, drug (25) 25
time factors (25) 25
cognition - drug effects (24) 24
neurocognitive function (24) 24
antipsychotic agents - adverse effects (23) 23
children (23) 23
hiv (23) 23
neurology (23) 23
neurotoxicity (23) 23
risk factors (23) 23
young adult (23) 23
child, preschool (22) 22
diagnosis, differential (22) 22
cognition disorders - psychology (20) 20
mental disorders - chemically induced (20) 20
psychology (20) 20
central-nervous-system (19) 19
anesthesia (18) 18
antipsychotic agents - therapeutic use (18) 18
cancer (18) 18
cognition disorders - diagnosis (18) 18
delirium, dementia, amnestic, cognitive disorders (18) 18
diseases (18) 18
drug therapy (18) 18
memory disorders - chemically induced (18) 18
substance abuse (18) 18
cognition disorders - etiology (17) 17
health aspects (17) 17
infectious diseases (17) 17
mice (17) 17
nervous system diseases (17) 17
neuropsychology (17) 17
organic mental disorders (17) 17
research (17) 17
virology (17) 17
alzheimers-disease (16) 16
brain - pathology (16) 16
cognitive ability (16) 16
dementia (16) 16
electroencephalography (16) 16
immunology (16) 16
neurocognitive disorders - complications (16) 16
anesthesiology (15) 15
bipolar disorder - drug therapy (15) 15
cohort studies (15) 15
hiv infections - drug therapy (15) 15
j ve psychiatry (15) 15
nervous system diseases - chemically induced (15) 15
occupational diseases - chemically induced (15) 15
oxidative stress (15) 15
pediatrics (15) 15
chemotherapy (14) 14
follow-up studies (14) 14
neurocognitive disorders - physiopathology (14) 14
neuropsychiatry (14) 14
brain - physiopathology (13) 13
cognition disorders (13) 13
drug administration schedule (13) 13
drug therapy, combination (13) 13
drugs (13) 13
exposure (13) 13
infant (13) 13
nervous system (13) 13
neurocognitive (13) 13
neurons (13) 13
oncology (13) 13
toxicology (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Providence Healthcare - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (327) 327
German (17) 17
French (7) 7
Russian (5) 5
Polish (3) 3
Dutch (2) 2
Japanese (1) 1
Norwegian (1) 1
Romanian (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Epilepsia, ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Summary Many symptoms of neurologic or psychiatric illness—such as cognitive impairment, depression, anxiety, attention deficits, and migraine—occur more... 
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | DEPRESSIVE-LIKE BEHAVIOR | TEMPORAL-LOBE EPILEPSY | GENETIC ABSENCE EPILEPSY | ENVIRONMENTAL ENRICHMENT | KETOGENIC DIET | CLINICAL NEUROLOGY | TRAUMATIC BRAIN-INJURY | EARLY-LIFE SEIZURES | SPATIAL MEMORY | INDUCED STATUS EPILEPTICUS | IMMATURE RATS | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life
Journal Article
Experimental Neurology, ISSN 0014-4886, 2008, Volume 213, Issue 1, pp. 71 - 83
Patients with temporal lobe epilepsy are frequently afflicted with psychiatric comorbidity and deficits in spatial and other forms of declarative memory. The... 
Learning and memory | Hippocampal sclerosis | Depression | Anxiety | Psychopathology | Glutamate | Seizures | WATER-MAZE | hippocampal sclerosis | PSYCHIATRIC COMORBIDITY | KAINIC ACID | GRANULE CELL DISPERSION | NEUROSCIENCES | anxiety | ANTIDEPRESSANT ACTIVITY | learning and memory | psychopathology | PILOCARPINE MODEL | seizures | RAT HIPPOCAMPUS | depression | INDUCED STATUS EPILEPTICUS | SPONTANEOUS RECURRENT SEIZURES | glutamate | Epilepsy, Temporal Lobe - psychology | Memory Disorders - physiopathology | Nerve Degeneration - physiopathology | Status Epilepticus - chemically induced | Epilepsy, Temporal Lobe - physiopathology | Learning Disorders - physiopathology | Hippocampus - drug effects | Dentate Gyrus - physiopathology | Nerve Degeneration - chemically induced | Dentate Gyrus - drug effects | Female | Depressive Disorder - chemically induced | Disease Models, Animal | Mood Disorders - chemically induced | Mental Disorders - chemically induced | Epilepsy, Temporal Lobe - chemically induced | Kainic Acid - pharmacology | Status Epilepticus - pathology | Neurocognitive Disorders - physiopathology | Excitatory Amino Acid Agonists - pharmacology | Hippocampus - pathology | Neurocognitive Disorders - chemically induced | Maze Learning - drug effects | Nerve Degeneration - pathology | Mental Disorders - physiopathology | Neuropsychological Tests | Learning Disorders - chemically induced | Animals | Depressive Disorder - physiopathology | Status Epilepticus - physiopathology | Convulsants - pharmacology | Mice | Mood Disorders - physiopathology | Dentate Gyrus - pathology | Hippocampus - physiopathology | Memory Disorders - chemically induced | Temporal lobe epilepsy | Index Medicus
Journal Article
Brain Research Bulletin, ISSN 0361-9230, 2016, Volume 124, pp. 164 - 171
Journal Article
Neuroscience, ISSN 0306-4522, 2011, Volume 196, pp. 237 - 250
Abstract Sleep disordered breathing (SDB), which is characterized by intermittent hypoxia (IH) during sleep, causes substantial cardiovascular and... 
Neurology | neurocognitive dysfunction | sleep disordered breathing | growth hormone | Growth hormone | Neurocognitive dysfunction | Sleep disordered breathing | NEURONAL APOPTOSIS | ERYTHROPOIETIN PROTECTS | OBSTRUCTIVE SLEEP-APNEA | OXIDATIVE STRESS | FACTOR-I | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | SPATIAL-LEARNING DEFICITS | GENE-EXPRESSION | POSITIVE AIRWAY PRESSURE | CEREBRAL-ISCHEMIA | Vascular Endothelial Growth Factor A - biosynthesis | Hypoxia - drug therapy | Cognition Disorders - chemically induced | Humans | Caspase 3 - metabolism | Cognition Disorders - metabolism | Male | Growth Hormone - biosynthesis | Hippocampus - drug effects | Hypoxia - metabolism | Glucose Transporter Type 1 - biosynthesis | Erythropoietin - biosynthesis | Cognition Disorders - psychology | Disease Models, Animal | Hypoxia - psychology | Insulin-Like Growth Factor I - biosynthesis | Heme Oxygenase-1 - biosynthesis | Receptors, Somatotropin - biosynthesis | Rats | Hypoxia - complications | Cognition Disorders - drug therapy | Maze Learning - drug effects | Rats, Sprague-Dawley | Hippocampus - metabolism | Cognition Disorders - complications | Animals | Growth Hormone - therapeutic use | Neurosciences | Erythropoietin | Glucose | Dextrose | Endothelium | Somatotropin | Sleep disorders | Sleep | Messenger RNA | Heme | Vascular endothelial growth factor | Health aspects | Public health | Vascular Endothelial Growth Factor A | Anoxia | Growth Hormone | Glucose Transporter Type 1 | Insulin-Like Growth Factor I | Receptors, Somatotropin | Life Sciences | Maze Learning | Cognition Disorders | Caspase 3 | Heme Oxygenase-1 | Hippocampus | Cancer
Journal Article
Journal Article
Journal of Neuroimmune Pharmacology, ISSN 1557-1890, 9/2016, Volume 11, Issue 3, pp. 495 - 510
Journal Article